Get the content you want anytime you want.
REGISTER NOW | SIGN IN

Select coverage from Infectious Disease Week is included below:

What is the First-line Empiric Therapy for Candidemia?
Monica Mahoney, PharmD, BCPS-AQ ID, explains the first-line empiric therapy for candidemia.
APX001: A New Antifungal with Activity Against <i>Candida auris</i>
Ciara Kennedy, PhD, breaks down APX001, a new antifungal with a unique mechanism of action.
Top 5 <i>Contagion</i>® News Articles for the Week of October 8, 2017
Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.
As the World Is Hit with Vaccine Shortages, Will This Mosquito-Borne Virus Find Its Way to Asia?
Dr. Daniel Lucey provided insight on past and current yellow fever outbreaks and vaccine shortages at ID Week 2017; he also cited the very real possibility of yellow fever hitting Asia.
What is the Advantage of Administering a Beta-Lactam with a Beta-Lactamase Inhibitor?
Amanda Paschke, MD, MSCE, explains the advantage of administering a beta-lactam in combination with a beta-lactamase inhibitor.
Letermovir Protective in Cytomegalovirus-Positive Recipients of Allogeneic Hematopoietic Cell Transplantation
Results from a randomized, double-blind, placebo-controlled trial show that letermovir protects from viral infection in CMV-seropositive individuals following allogeneic hematopoietic cell transplantation.
Fosfomycin: A Novel Epoxide Antimicrobial
Evelyn J. Ellis-Grosse, PhD, chief scientific officer of Zavante Therapeutics, explains why Zavante Therapeutic’s fosfomycin is a unique, novel antimicrobial.
The Challenge of Eliminating Hepatitis C Virus in the United States
The ambitious goal of global elimination of the virus by 2030 will take buy-in from all major stakeholders, including the United States.
FEATURED
We break down our top HIV news stories of 2017. Did you read them all?
x